Sinopharm Group Co. Ltd. (SHTDF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:40AM EDT. Market open.
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
596,569,565
596,569,565
552,147,550
521,051,235
456,414,611
Cost of revenue
548,057,887
548,057,887
504,713,490
477,000,627
416,091,300
Gross profit
48,511,678
48,511,678
47,434,060
44,050,608
40,323,311
Operating expenses
Selling general and administrative
26,149,763
26,149,763
24,903,120
23,198,526
21,191,553
Total operating expenses
26,234,719
26,234,719
24,893,424
22,609,333
20,539,551
Operating income or loss
17,758,347
22,276,959
22,540,636
21,441,275
19,783,760
Interest expense
3,444,856
2,956,587
3,520,326
3,756,835
3,424,756
Income before tax
19,512,137
19,512,137
18,563,819
17,003,162
15,598,096
Income tax expense
4,502,309
4,502,309
4,218,377
3,938,389
3,500,805
Income from continuing operations
15,009,828
15,009,828
14,345,442
13,064,773
12,097,291
Net income
9,053,760
9,053,760
8,525,655
7,758,646
7,187,278
Net income available to common shareholders
9,053,760
9,053,760
8,525,655
7,758,646
7,187,204
Basic EPS
2.81
-
2.73
2.49
2.31
Diluted EPS
2.81
-
2.73
2.49
2.31
Basic average shares
3,116,890
-
3,120,656
3,111,169
3,111,169
Diluted average shares
3,116,890
-
3,120,656
3,111,169
3,111,293
© 2024 Yahoo. All rights reserved.